Romano Kathryn's Form 4 filing
Krystal Biotech, Inc. (KRYS) · filed Mar 1, 2024
- Accession no.
- 0001801385-24-000011
- Filed
- Mar 1, 2024
- Trade date
- Feb 28-29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 18 non-derivative transactions and 3 derivative transactions. Open-market sales total $829.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Romano KathrynCIK 0001801385 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +648 | $63.55 | +$41,180.4 | 13,584 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −648 | $162.71F2 | −$105,436.08 | 12,936 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +900 | $63.55 | +$57,195 | 13,836 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −900 | $163.68F3 | −$147,312 | 12,936 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +1,429 | $63.55 | +$90,812.95 | 14,365 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −1,429 | $164.81F4 | −$235,513.49 | 12,936 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +300 | $63.55 | +$19,065 | 13,236 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −300 | $166.06F5 | −$49,818 | 12,936 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +300 | $63.55 | +$19,065 | 13,236 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −300 | $167.85F6 | −$50,355 | 12,936 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +1,216 | $63.55 | +$77,276.8 | 14,152 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −1,216 | $169.09F7 | −$205,613.44 | 12,936 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +117 | $63.55 | +$7,435.35 | 13,053 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −117 | $169.82F8 | −$19,868.94 | 12,936 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +90 | $63.55 | +$5,719.5 | 13,026 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −90 | $172.23 | −$15,500.7 | 12,936 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +5,000 | $0.00 | $0 | 17,936 | Direct | |
| Feb 28, 2024 | Common Stock | FTax withholdingDisposed | −2,314 | $163.08F11 | −$377,367.12 | 15,622 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 25,000 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 5,000 | Direct | |
| Feb 29, 2024 | Common Stock | AGrant or awardAcquired | +15,000 | $0.00 | $0 | 15,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The transaction was executed in multiple trades ranging from $162.155 to $163.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F3
The transaction was executed in multiple trades ranging from $163.190 to $164.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F4
The transaction was executed in multiple trades ranging from $164.300 to $165.220. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F5
The transaction was executed in multiple trades ranging from $165.980 to $166.110. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F6
The transaction was executed in multiple trades ranging from$167.540 to $168.010. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F7
The transaction was executed in multiple trades ranging from $168.680 to $169.610. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F8
The transaction was executed in multiple trades ranging from $169.790 to $170.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F11
The closing price on February 28, 2024 of the Company's common stock on NASDAQ.
Referenced by the price of 1 transaction in Table I.